Exanthematous reaction to irbesartan.
Gambini
D
D
Sala
F
F
Gianotti
R
R
Cusini
M
M
D000368:Aged; D001707:Biopsy, Needle; D001713:Biphenyl Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology*; D004359:Drug Therapy, Combination; D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology*; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D007150:Immunohistochemistry; D000077405:Irbesartan; D007676:Kidney Failure, Chronic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D012720:Severity of Illness Index; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use
D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan